TFT-Based Life Sciences Product Line

TFT-DNA synthesis solutions balancing throughput, yield, and length

TruSynthTM
Oligo Microarray Synthesizer

World's first oligonucleotide microarray synthesizer based on TFT semiconductor technology

High-Throughput oligo microarray and oligo pool production tools integrate TFT semiconductor technology with electrochemical technology

TruArray®

Oligo Microarray

TruPool®

Oligo Pool

Why Choose TFT Semiconductor?

Low Cost

Mainland China holds approximately 80% of global TFT semiconductor production capacity, with world-leading design and fabrication capabilities, serving as a vital engine for the rapid iteration of TFT-based life science tools

High Precision

Array density reaches single-cell and subcellular resolution, perfectly adapted for single-cell and picoliter-to-microliter molecular experiments

High Throughput

Leveraging mature display technology, pixel arrays ranging from thousands to tens of millions can be easily achieved

Industrial Chain Advantage

Leveraging established processes and production capacity to break the stereotype of “expensive semiconductor consumables”

Integration

TFT enables the accomplishment of successive tasks in multi-step workflows, involving varying throughput and sample load, on a single chip, which includes reaction system construction, reaction process control, and in situ result detection

Large-Area Scalability

Mass-produced chips can reach square-meter scale, overcoming the capacity limits of silicon-based semiconductors and traditional microfluidics

Three Fundamental Capabilities of TFT Biochips

Microarray Reaction Control

Realize various synthesis Schemes (e.g. electronic, photonic, temperature, and enzymatic catalyst) with high throughput and capacity

Picoliter Droplet Manipulation

Realize high-throughput mixing, moving, splitting, and other precise manipulations of biological sample droplets from picoliter to microliter

In-situ Signal Sensing

Realize high-throughput, accurate, fast, and sensitive real-time sensing of in situ biological signals by integrating various advanced solutions

Pioneering the Next Generation of
Semiconductor Tools for Life Sciences

Dr. Kang Kang

Partner & CBio

Dr. Kang received his Ph.D. in Bioinformatics and Systems Biology from the University of Hong Kong in 2018, then became a scientific co-worker of the Leibniz Association (Leibniz-HKI) and a visiting scientist at the Novo Nordisk Foundation Center for Biosustainability (DTU Biosustain) at the Technical University of Denmark. He was a scientist at BGI-Shenzhen and co-founded the synthetic biology research group. He was a senior bioinformatics engineer and brand advisor at WeGene. In 2021, Kang joined Biosysen Limited as a co-founder and served as Chief Informatics Scientist. He is also an advisor and author of the biotech media "Regenesis". He has been dedicated to the R&D and industrialization of OMICs technologies, high-throughput technologies, and synthetic biology for over 10 years. He joined LinkZill in March 2023, responsible for semiconductor life science tools and product planning.